SCHEMBL2116820

SCHEMBL2116820

Cc1cc(NS(=O)(=O)c2csc(C)c2)cc(-c2nnco2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
PSEN1 P49768 1/20 0.47
PSEN2 P49810 1/20 0.47
APH1B Q8WW43 1/20 0.47
NCSTN Q92542 1/20 0.47
APH1A Q96BI3 1/20 0.47
PSENEN Q9NZ42 1/20 0.47
MAPT P10636 5/20 0.40
TP53 P04637 3/20 0.40
ALDH1A1 P00352 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TSHR P16473 2/20 0.38
NOTUM Q6P988 1/20 0.38
HPGD P15428 2/20 0.35
EDNRB P24530 1/20 0.34
EDNRA P25101 1/20 0.34
HTT P42858 1/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2119637 0.81 GAA (0.49) GAACYP3A4CYP2D6PSEN1PSEN2
SCHEMBL2117139 0.79 TP53 (0.46) GAACYP3A4CYP2D6PSEN1PSEN2
SCHEMBL2118085 0.78 HPGD (0.55) GAACYP3A4CYP2D6PSEN1PSEN2
SCHEMBL2119867 0.77 GAA (0.48) GAACYP3A4CYP2D6PSEN1PSEN2
SCHEMBL2119912 0.76 GAA (0.47) GAACYP3A4CYP2D6PSEN1PSEN2
SCHEMBL2117286 0.75 SYK (0.48) GAACYP3A4CYP2D6PSEN1PSEN2
SCHEMBL2117794 0.73 MAPT (0.44) GAACYP3A4CYP2D6PSEN1PSEN2
SCHEMBL2119710 0.72 GAA (0.43) GAACYP3A4CYP2D6PSEN1PSEN2
SCHEMBL16982635 0.70 NOTUM (0.64) MAPTALDH1A1TSHRNOTUMHPGD
SCHEMBL2117885 0.68 ALDH1A1 (0.37) MAPTTP53ALDH1A1NPSR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120095012-A1 TOLUIDINE SULFONAMIDES AND THEIR USE ELARA PHARMACEUTICALS GMBH (DE) 2012-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120095012-A1 TOLUIDINE SULFONAMIDES AND THEIR USE HIF1A, HIF1AN, EGLN3 GAA 501/4885CYP3A4 1975/4885CYP2D6 2336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.